未来基于纳米技术的战略,以改善对Helicobacter pylori感染的管理
Mojtaba Kamankesh1, Abbas Yadegar2, Antoni Llopis-Lorente3
1Polymer Chemistry Department, School of Science, University of Tehran, PO Box 14155-6455, Tehran, 14144-6455, Iran.
Small (Weinheim an der Bergstrasse, Germany)
|September 11, 2023
概括
新型纳米配送系统提供了一种有前途的策略来对抗Helicobacter pylori (H. pylori) 感染. 这些先进的平台旨在提高治疗效率,同时尽量减少抗生素耐药性和保护有益的肠道微生物群.
科学领域:
- 纳米技术在医学中的应用
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌 (H. pylori) 是胃部疾病的重要原因之一.
- 目前针对H. pylori的多药疗法导致微生物群的破坏和抗生素耐药性.
- 迫切需要更简单,更有效的抗H. pylori策略.
研究的目的:
- 总结一下纳米结构药物输送系统在H. pylori治疗中的最新进展.
- 提出一种新的药物释放模式和IVIVC模型,以预防H. pylori抗生素耐药性.
- 讨论针对H. pylori根除的本地和工程传递系统.
主要方法:
- 对纳米结构药物递送系统的审查,包括粘膜粘合,粘膜透和细胞粘合纳米生物材料.
- 讨论工程平台,如聚合物涂层纳米乳液和纳米脂质体.
- 关于药物释放范式和体外-体内相关性 (IVIVC) 模型的建议.
主要成果:
- 纳米生物材料为H. pylori感染提供了有针对性的局部传递.
- 工程纳米平台可以封装抗菌剂以进行智能交付.
- 拟议的系统旨在预防抗生素耐药性,并尽量减少对肠道微生物群的伤害.
结论:
- 纳米结构的输送系统是克服H. pylori挑战的有希望的方法.
- 这些先进的配方可以专门针对H. pylori,同时保留宿主微生物群.
- 进一步的检查点对于验证抗H. pylori纳米系统的临床有效性至关重要.
更多相关视频
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
442
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
442
01:26Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
463
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
463
01:28Biological Methods for Microbial Control
61
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
61
01:23Gastritis III: Clinical Manifestations and Management
319
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
319
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
460
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
460